New Fortress Energy
NFE
Lantheus
LNTH
Dorian LPG
LPG
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
OSTX OS Therapies
- 1.510
- +0.070+4.86%
Close Mar 4 16:00 ET
- 1.569
- +0.059+3.87%
Post 19:51 ET
33.11MMarket Cap-4.31P/E (TTM)
1.550High1.415Low178.02KVolume1.450Open1.440Pre Close261.68KTurnover1.18%Turnover RatioLossP/E (Static)21.93MShares7.00052wk High-47.19P/B22.70MFloat Cap1.41052wk Low--Dividend TTM15.03MShs Float7.000Historical High--Div YieldTTM9.38%Amplitude1.410Historical Low1.469Avg Price1Lot Size
About OS Therapies Company
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.
Company Profile
SymbolOSTX
Company NameOS Therapies
Listing DateAug 1, 2024
Issue Price4.00
Founded2018
CEOMr. Paul A. Romness, M.P.H.
MarketAMEX
Employees4
Fiscal Year Ends12-31
Address15825 Shady Grove Road,Suite 135
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-410-297-7793
Websitehttp://www.ostherapies.com
Company Executives
- Name
- Position
- Salary
- Paul A. Romness, M.P.H.
- President, Chief Executive Officer and Director
- 360.00K
- Gerald E. Commissiong
- Chief Business Officer
- --
- Christopher P. Acevedo
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Robert G. Petit, PhD
- Chief Medical Officer and Chief Scientific Officer
- 360.00K
- Karim Galzahr
- Director
- --
- John Ciccio
- Independent Director
- 40.00
- Dr. Theodore F. Search, Pharm.D.,R.Ph.
- Independent Director
- 40.00
- Avril Suzette McKean-Dieser, J.D.
- Independent Director
- --
- Olivier R. Jarry, M.B.A.,M.S.
- Independent Director
- --